Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jul 23;582(17):2527-31.
doi: 10.1016/j.febslet.2008.06.017. Epub 2008 Jun 20.

Zinc regulation of aminopeptidase B involved in neuropeptide production

Affiliations

Zinc regulation of aminopeptidase B involved in neuropeptide production

Shin-Rong Hwang et al. FEBS Lett. .

Abstract

Aminopeptidase B (AP-B) is a metallopeptidase that removes basic residues from the N-termini of neuropeptide substrates in secretory vesicles. This study assessed zinc regulation of AP-B activity, since secretory vesicles contain endogenous zinc. AP-B was inhibited by zinc at concentrations typically present in secretory vesicles. Zinc effects were dependent on concentration, incubation time, and the molar ratio of zinc to enzyme. AP-B activity was recovered upon removal of zinc. AP-B with zinc became susceptible to degradation by trypsin, suggesting that zinc alters enzyme conformation. Zinc regulation demonstrates the metallopeptidase property of AP-B.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Zinc inhibition of aminopeptidase B (AP-B) at in vivo levels of zinc in secretory vesicles
AP-B activity was assessed at different concentrations of zinc of 5–80 μM ZnCl2). AP-B (22 nM) was monitored with Arg-MCA substrate, with aminopeptidase activity detected by the formation of fluorescent AMC (aminomethylcoumarinamide). Results show inhibition of AP-B by zinc in a concentration-dependent manner.
Figure 2
Figure 2. Zinc regulation of AP-B
Aminopeptidase B (AP-B, 22 nM) was assessed at different concentrations of ZnCl2 in time course assays that monitored activity at 10, 15, 30, and 45 minutes of incubation. AP-B activity was expressed as percent of control AP-B activity (100%) assayed in the absence of zinc.
Figure 3
Figure 3. Effects of different molar ratios of zinc to AP-B for aminopeptidase activity
AP-B was assayed in the presence of ZnCl2 (0.5 μM) at different molar ratios of 80, 40, and 20 of zinc to AP-B at 37°C for 60 min. The percent inhibition of AP-B relative to AP-B control without zinc (0% inhibition) is shown. The mean of replicate assays (triplicate) with s.e.m. (standard error of the mean) is shown.
Figure 4
Figure 4. Analysis of zinc inhibition of AP-B by Lineweaver-Burk plot
Inhibition of AP-B (22 nM) by zinc (at 1, 2, 5, and 10 μM) was assessed by inverse Lineweaver-Burk plots [15], which indicated zinc as a mixed inhibitor. The Lineweaver-Burk plot also showed that AP-B (without zinc) has Km value of 27 μM Arg-MCA and Vmax of 1.2 μM/min. The Ki and Ki′ values for zinc inhibition of enzyme and enzyme/substrate complexes were calculated as 6 μM and 12 μM zinc, respectively.
Figure 5
Figure 5. Reversibility of zinc inhibition of AP-B
AP-B (22 nM) was incubated with ZnCl2 (50 μM) for 5 min., and was then assayed for AP-B activity with different incubation times (2–75 min.). AP-B activity without removal of zinc (○), and after removal of ZnCl2 by one (▲) or two (□) desalting column steps, was assessed. Recovery of AP-B activity is evident upon removal of ZnCl2.
Figure 6
Figure 6. Zinc increases susceptibility of AP-B to degradation by trypsin
Purified AP-B (835 ng) was incubated without (lane 1) or with (lane 2) ZnCl2 (250 μM) (for 5 min.), and was then subjected to incubation with trypsin (50 ng) at 30°C for 40 minutes. The integrity AP-B was then assessed by western blots with anti-AP-B, with equal amounts of AP-B (58 ng) present in each of lanes 1 and 2. Results show that zinc induced the susceptibility of AP-B to degradation by trypsin.

Similar articles

Cited by

References

    1. Yasothornsrikul S, Greenbaum D, Medzihradszky KF, Toneff T, Bundey R, Miller R, Schilling B, Petermann I, Dehnert J, Logvinova A, Goldsmith P, Neveu JM, Lane WS, Gibson B, Reinheckel T, Peters C, Bogyo M, Hook V. Cathepsin L in secretory vesicles functions as a prohormone-processing enzyme for production of the enkephalin peptide neurotransmitter. Proc Natl Acad Sci USA. 2003;100:9590–9595. - PMC - PubMed
    1. Hwang SR, Garza C, Mosier C, Toneff T, Wunderlich E, Goldsmith P, Hook V. Cathepsin L expression is directed to secretory vesicles for enkephalin neuropeptide biosynthesis and secretion. J Biol Chem. 2007;282:9556–9563. - PubMed
    1. Hook V, Funkelstein L, Lu D, Bark S, Wegrzyn J, Hwang SR. Proteases for processing proneuropeptides into peptide neurotransmitters and hormones. Annu Rev Pharmacol Tox. 2008;48:393–423. - PMC - PubMed
    1. Zhou A, Webb G, Zhu X, Steiner DF. Proteolytic processing in the secretory pathway. J Biol Chem. 1999;274:20745–20748. - PubMed
    1. Seidah NG, Prat A. Precursor convertases in the secretory pathway, cytosol, and extracellular milieu. Essays Biochem. 2002;38:79–94. - PubMed

Publication types